MedCity News

Willow Acquires 2 Women’s Health Companies

Patient Deaths and Data Shortfall Spell the End for Cell Therapy Biotech Artiva

Artiva Biotherapeutics attributed one of the fatalities to a drug used to prepare patients for cell therapy and not to the cell therapy itself. But Artiva’s setbacks follow safety signals reported for autoimmune disease cell therapy programs from Novartis and Bristol Myers Squibb.

By Frank Vinluan

Payers, Health Tech, Providers

ClarityCare Raises $16.5M to Speed Up Prior Authorizations

As health plans grapple with new federal deadlines for prior authorization decisions, healthcare AI startup ClarityCare has raised $16.5 million to automate the administrative workload that can keep patients waiting for the care they need.

By Jenna Congdon

MedCity Influencers

A Market, Not a Mandate, Is the Fastest Way to Bring AI Into Hospitals

The cost of waiting is not evenly distributed. Rural and critical access hospitals report under 50 percent adoption of even basic predictive tools, compared with 86 percent among top-tier system-affiliated hospitals. Every year without a bridge widens that gap, and it widens it fastest for the hospitals with the least room to absorb it.

By Dr. Andrew M. Ibrahim

Latest Video

Latest News

Health Tech

Vitalize Secures $31M To Help Hospitals Manage Labor, Capacity

The Series A round was led by Oak HC/FT, with participation from Norwest, .406 Ventures, Constellation Ventures, Y Combinator, Rock Health Capital and MemorialCare Innovation Fund.

By Marissa Plescia

MedCity Influencers

alzheimer's, memory loss and senile dementure

AI Can Flag Cognitive Decline Earlier — Health Systems Still Own What Happens Next

Earlier detection is valuable, but it creates a duty that does not end when an alert appears in the electronic health record. Health systems need to decide, in advance, how a risk signal becomes a clinically accountable pathway.

By Nargiz Noimann

Payers, Providers

Trilliant Health: Misaligned Incentives Are Undermining US Healthcare

Trilliant Health’s report identifies six trends highlighting how misaligned incentives are contributing to rising costs, poor health outcomes, workforce shortages and other systemic problems in U.S. healthcare.

By Marissa Plescia

Health Tech, Artificial Intelligence

Teladoc Health Adds Contactless Vitals and Ambient AI Scribe to Virtual Visit Platform

Teladoc Health announced Wednesday that it is launching two new AI-powered capabilities built into its Solo smart care platform for hospitals and health systems to be used during virtual visits.

By Jenna Congdon

BioPharma, Pharma

Caribou Bio’s Journey With Off-the-Shelf Cell Therapy Reaches the End of the Road

Caribou Biosciences is stopping work on its two remaining cancer cell therapies and exploring strategic alternatives for the business. The move follows the CRISPR biotech company’s failure to secure financing for its clinical trial plans.

By Frank Vinluan

MedCity Influencers

close-up studio macro shot of various pills on US dollar bills.

PBM Transparency Is Still Too Opaque — How Can Employers Rein In Drug Costs?

Employers are trying to comparison shop in a market where all the price tags are hidden. And most can’t simply switch PBMs to find better pricing for their members.

By Christine Johnston

MedCity Influencers

Why Pharma Companies Should Look To Social Media For Better Patient Insight

Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.

By Rohit Marwah

MedCity Influencers

From Distributor to Disruptor: Amazon’s Healthcare Flex

No longer satisfied with buying pharmacies and clinics, it seems intent on owning the healthcare journey, and perhaps redrawing pharma’s commercialization map.

By Adrienne Lovink

Providers

Cybersecurity Experts to Hospital Leaders: Think Beyond Traditional Disaster-Recovery Planning

Cybersecurity leaders discussed how AI-driven cybersecurity attacks pose a new level of risk for hospitals and health systems at Rubrik's Healthcare Summit last week.

By Jenna Congdon

Providers, Policy

FTC Sends Warning Letters to 24 Healthcare Organizations Over Price Transparency

The FTC sent warning letters to 24 major healthcare organizations over concerns about inadequate price transparency.

By Marissa Plescia

BioPharma, Startups

Forbion Bucks VC Fundraising Trends, Reeling In €2.3B for Two New Funds

Forbion’s new capital will support two funds that will invest in about 30 companies combined. The new funds for Netherlands-based Forbion come amid a decline in VC fundraising and investments in Europe, according to Pitchbook.

By Frank Vinluan

MedCity Influencers

Perimenopause Anxiety: Sometimes It’s a Progesterone Deficiency

Perimenopausal anxiety isn't simply in our patients' heads. It's often the result of complex physiologic changes involving hormones, sleep, metabolism, and the nervous system.

By Lexi Yoo

MedCity Influencers

MedTech VC 2026: The Real Story vs. The Thesis

I kept hearing “medtech VC is in decline,” so I decided to dig into the data myself. I expected shrinking investor interest, inflated valuations, and a weak exit environment. Instead, I found a more nuanced story.

By Jordan Lisnow

Hidden Risks and Costs of Maternal/Infant Health that Health Plans Miss

A new report from ProgenyHealth offers a window into how the business works with commercial and Medicaid plans to close gaps in maternity and NICU care management that traditional programs overlook.

By Stephanie Baum

Health Tech

Investing in Community Health: A New Model for Safety-Net Healthcare Innovation

Launched last week, Facktor Ventures, an early-stage venture fund is taking a new approach to healthcare investing: they’re structured so that the organizations delivering care on the ground collectively become majority owners of the fund as limited partners.

By Jenna Congdon